SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

78,639.03 544.39
( 0.70%)

Global Indices

Nasdaq

53,210.99 704.96
(1.34%)

Dow Jones

7,621.51 110.79
(1.48%)

Hang Seng

63,705.00 -657.02
(-1.02%)

Nikkei 225

10,850.37 -17.68
(-0.16%)

Forex

USD-INR

95.59 -0.10
(-0.11%)

EUR-INR

109.79 0.65
(0.59%)

GBP-INR

128.11 0.75
(0.59%)

JPY-INR

0.59 0.01
(1.09%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Gufic BioSciences Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

509079

INE742B01025

66.2307167

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GUFICBIO

62.02

3918.04

EPS(TTM)

Face Value()

Div & Yield %

6.3

0.03

Back

Shrenik reports standalone net loss of Rs 0.20 crore in the June 2026 quarter

Jul 30,2026

Net Loss of Shrenik reported to Rs 0.20 crore in the quarter ended June 2026 as against net loss of Rs 0.07 crore during the previous quarter ended June 2025. Sales rose 7.38% to Rs 6.26 crore in the quarter ended June 2026 as against Rs 5.83 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	6.26	5.83	7
OPM %	-10.06	-7.89	-
PBDT	-0.20	-0.07	-186
PBT	-0.20	-0.07	-186
NP	-0.20	-0.07	-186

78,639.03 544.39 ( 0.70%)

53,210.99 704.96 (1.34%)

7,621.51 110.79 (1.48%)

63,705.00 -657.02 (-1.02%)

10,850.37 -17.68 (-0.16%)

95.59 -0.10 (-0.11%)

109.79 0.65 (0.59%)

128.11 0.75 (0.59%)

0.59 0.01 (1.09%)